Valuation: Arcadia Biosciences, Inc.

Market Cap 397K 353K 327K 298K 562K 37.68M 571K 3.93M 1.54M 19.66M 1.49M 1.46M 62.69M P/E 2024
-1.15x
P/E 2025 -1.16x
Enterprise Value -4.17M -3.7M -3.43M -3.12M -5.89M -395M -5.99M -41.26M -16.18M -206M -15.63M -15.3M -658M EV / Sales 2024
0.79x
EV / Sales 2025 -0.38x
Free-Float
84.13%
Yield 2024 *
-
Yield 2025 -
1 day-13.23%
1 week-31.42%
Current month-44.64%
1 month-64.77%
3 months-76.62%
6 months-86.10%
Current year-92.17%
1 week 0.16
Extreme 0.155
0.23
1 month 0.16
Extreme 0.155
0.68
Current year 0.16
Extreme 0.155
2.75
1 year 0.16
Extreme 0.155
5.23
3 years 0.16
Extreme 0.155
10.31
5 years 0.16
Extreme 0.155
106.4
10 years 0.16
Extreme 0.155
2,662.4
Manager TitleAgeSince
Chief Executive Officer 50 05/07/2024
Director TitleAgeSince
Chairman 57 22/11/2017
Director/Board Member 76 13/06/2017
Director/Board Member 58 10/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 A Free

Director

10,000 0.4151%
9/10/26 A Free

Chairman

23,000 0.9547%
9/10/26 A Free

Director

10,000 0.4151%
Change 5-day change 1-year change 3-year change Capi.($)
-13.23%-31.42%-96.85%-95.27% 397K
-0.33%+7.38%-2.30%-16.94% 257B
-0.20%+2.75%+1.08%-1.12% 81.57B
0.00%+0.08%+22.14%+541.41% 45.82B
-1.49%+2.36%-21.88%+12.24% 44.55B
-0.18%+2.72%+30.72%+11.87% 39.81B
-0.57%+3.59%-8.86%-11.41% 34.32B
-0.32%-2.52%+26.33%+84.31% 31.92B
-1.18%+1.60%-12.46%-6.22% 29.68B
-0.89%+4.21%-9.00%-25.61% 28.08B
Average -1.84%-0.48%-7.11%+49.33% 59.31B
Weighted average by Cap. -0.45%+5.57%+1.14%+38.39%

Financials

2024 2025
Net sales 5.04M 4.48M 4.16M 3.78M 7.14M 479M 7.25M 49.96M 19.59M 250M 18.93M 18.53M 797M 4.86M 4.32M 4M 3.64M 6.87M 461M 6.98M 48.11M 18.86M 241M 18.23M 17.84M 767M
Net income -7.04M -6.26M -5.8M -5.28M -9.96M -668M -10.12M -69.7M -27.33M -349M -26.41M -25.85M -1.11B -2.34M -2.08M -1.93M -1.75M -3.31M -222M -3.36M -23.16M -9.08M -116M -8.78M -8.59M -369M
Net Debt -4.09M -3.63M -3.37M -3.06M -5.78M -388M -5.87M -40.48M -15.87M -202M -15.34M -15.01M -645M -4.56M -4.06M -3.76M -3.42M -6.45M -433M -6.56M -45.19M -17.72M -226M -17.12M -16.76M -720M
Projected Income Statement - Annual - Arcadia Biosciences, Inc.
Logo Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Employees
8
Date Price Change Volume
19/10/26 $0.1550 -5.95% 95,663
16/10/26 $0.1648 -19.02% 988,377
15/10/26 $0.2035 +1.24% 726,136
14/10/26 $0.2010 -3.13% 33,836,898
13/10/26 $0.2075 -8.19% 21,283,456

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Arcadia Biosciences, Inc.
  1. Stock Market
  2. Stocks
  3. RKDA Stock